Evidence map›Paper›PMID 39934234›Full record

Articlenpj antimicrobials and resistance2025

Genomic survey of multidrug resistant Salmonella enterica serovar Minnesota clones in chicken products.

Jiayi Huang, Khaloud O Alzahrani, Ge Zhou, Shahad A Alsalman, Amani T Alsufyani, Nourah M Alotaibi, Saleh I Al-Akeel, Abdullah A Alajlan, Lenah E Mukhtar, Ayidh M Almansour and 17 more

Abstract read
In one paragraph

Article in npj antimicrobials and resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Genomic surveillance ofMicrobial genomics · 2026
    Article
  5. Multidrug-resistantFrontiers in microbiology · 2026
    Article
  6. A spotlight on multidrug-resistantFrontiers in microbiology · 2026
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Jiayi Huang *Laboratory of Infectious Disease Epidemiology, KAUST Center of Excellence for Smart Health and Biological and Environmental Science and Engineering (BESE) Division, King Abdullah University of Science and Technology (KAUST), Thuwal, Kingdom of Saudi Arabia.
Khaloud O Alzahrani *Saudi Food and Drug Authority (SFDA), Riyadh, Kingdom of Saudi Arabia.
Ge ZhouLaboratory of Infectious Disease Epidemiology, KAUST Center of Excellence for Smart Health and Biological and Environmental Science and Engineering (BESE) Division, King Abdullah University of Science and Technology (KAUST), Thuwal, Kingdom of Saudi Arabia.
Shahad A AlsalmanSaudi Food and Drug Authority (SFDA), Riyadh, Kingdom of Saudi Arabia.
Amani T AlsufyaniSaudi Food and Drug Authority (SFDA), Riyadh, Kingdom of Saudi Arabia.
Nourah M AlotaibiSaudi Food and Drug Authority (SFDA), Riyadh, Kingdom of Saudi Arabia.
Saleh I Al-AkeelSaudi Food and Drug Authority (SFDA), Riyadh, Kingdom of Saudi Arabia.
Abdullah A AlajlanSaudi Food and Drug Authority (SFDA), Riyadh, Kingdom of Saudi Arabia.
Lenah E MukhtarSaudi Food and Drug Authority (SFDA), Riyadh, Kingdom of Saudi Arabia.
Ayidh M AlmansourSaudi Food and Drug Authority (SFDA), Riyadh, Kingdom of Saudi Arabia.
Fahad M Al-ReshoodiSaudi Food and Drug Authority (SFDA), Riyadh, Kingdom of Saudi Arabia.
Malfi S Al RashidySaudi Food and Drug Authority (SFDA), Riyadh, Kingdom of Saudi Arabia.
Shaykhah AlhussainSaudi Food and Drug Authority (SFDA), Riyadh, Kingdom of Saudi Arabia.
Afnan AlthobaitiSaudi Food and Drug Authority (SFDA), Riyadh, Kingdom of Saudi Arabia.
Manal AlmusaSaudi Food and Drug Authority (SFDA), Riyadh, Kingdom of Saudi Arabia.
Talah AlmadiSaudi Food and Drug Authority (SFDA), Riyadh, Kingdom of Saudi Arabia.
Nouf AlmutairiSaudi Food and Drug Authority (SFDA), Riyadh, Kingdom of Saudi Arabia.
Abdulrahman AlzauhairSaudi Food and Drug Authority (SFDA), Riyadh, Kingdom of Saudi Arabia.
Meshari A AlhadlaqSaudi Food and Drug Authority (SFDA), Riyadh, Kingdom of Saudi Arabia.
Elaf AlshodokhiSaudi Food and Drug Authority (SFDA), Riyadh, Kingdom of Saudi Arabia.
Ashwag AlhamedSaudi Food and Drug Authority (SFDA), Riyadh, Kingdom of Saudi Arabia.
Abdulmohsen L AlHarbiSaudi Food and Drug Authority (SFDA), Riyadh, Kingdom of Saudi Arabia.
Manuel BanzhafNewcastle University Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Mathew MilnerLaboratory of Infectious Disease Epidemiology, KAUST Center of Excellence for Smart Health and Biological and Environmental Science and Engineering (BESE) Division, King Abdullah University of Science and Technology (KAUST), Thuwal, Kingdom of Saudi Arabia.
Mohammad AlArawiComputational Bioscience Research Center, King Abdullah University of Science and Technology (KAUST), Thuwal, Kingdom of Saudi Arabia.
Sulaiman M AlajelSaudi Food and Drug Authority (SFDA), Riyadh, Kingdom of Saudi Arabia. SMOtibi@sfda.gov.sa.
Danesh MoradigaravandLaboratory of Infectious Disease Epidemiology, KAUST Center of Excellence for Smart Health and Biological and Environmental Science and Engineering (BESE) Division, King Abdullah University of Science and Technology (KAUST), Thuwal, Kingdom of Saudi Arabia. danesh.moradigaravand@kaust.edu.sa.

Funding

King Abdullah University of Science and Technology BAS/1/1108-01-01
6 · The paper itself

Abstract

Salmonella enterica serovar Minnesota (S. Minnesota) is an emerging serovar that persists within poultry supply chains, potentially causing outbreaks in humans. Understanding its population genomics is crucial for designing preventive measures. We performed a genomic surveillance study of S. Minnesota by analyzing 259 isolates from poultry in Saudi Arabia. Whole-genome sequencing data for these isolates were analyzed to characterize emerging clones and the genetic factors underlying antimicrobial resistance and virulence. We compared the isolates to all available global genomes of S. Minnesota. Our results revealed the emergence of four clones, three of which were mixed with global strains. These clones exhibited higher levels of antimicrobial resistance and virulence due to the acquisition of multiple plasmids, particularly IncC plasmids, carrying resistance and virulence genes. IncC plasmids underwent genomic rearrangements, presenting diverse configurations of resistance genes. Our findings demonstrate the emergence and persistence of pathogenic and multidrug-resistant S. Minnesota clones.

Identifiers

PMID39934234
PMCPMC11814075

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.